Plasma enhanced magnetron sputtering (PEMS) for III-N materials on silicon substrates

Technology
In development
Company

Plasma Enhanced Magnetron Sputtering (PEMS) offers a scalable deposition process for III-N materials on silicon substrates, achieving high deposition rates and morphology control at reduced temperatures, crucial for large silicon wafer applications.

Overview

Plasma Enhanced Magnetron Sputtering (PEMS) is an advanced deposition process developed by Southwest Research Institute, designed specifically for III-N materials on silicon substrates. Combining traditional magnetron sputtering with a secondary, independently controlled plasma, PEMS achieves higher deposition rates and enhanced morphology control. This capability is critical for materials like AlN and GaN, allowing for deposition at significantly lower temperatures (350-450°C), which mitigates issues related to the coefficient of thermal expansion mismatch between GaN and Si. PEMS is particularly beneficial for scaling to larger silicon wafer diameters, as it controls layer stresses during growth, enabling the deposition of thick nitride materials.

Technical specifications
  • High deposition rates: PEMS surpasses advanced sputtering methods like HIPIMS in deposition efficiency.
  • Independently controlled plasma: Allows for precise control over ionization away from the sputtering target, enhancing morphology and stress control.
  • Lower deposition temperature: Operates at 350-450°C, compared to the 750°C and 900°C required for GaN and AlN respectively, in traditional methods.
  • Scalability: Suitable for large silicon wafers, reducing wafer bow and stress during deposition, with potential for scaling equipment for larger area and higher throughput applications.
Technology readiness level

The technology is currently at TRL 6, indicating it has been demonstrated in a relevant environment. Future validation steps include optimizing AlN on Si(111) to further reduce deposition temperatures and assess scalability for larger wafer sizes. Further research could explore different III-N materials or equipment scaling based on specific application needs.


About Southwest Research Institute

Southwest Research Institute (SwRI) is an independent, non-profit research organization providing contract research, development, and manufacturing services across biomedical and pharmaceutical development. It supports clients with FDA-inspected CGMP capabilities and expertise spanning process development, analytical and quality control, and scale-up to clinical and manufacturing stages.

Sign up to access the full partnering listing.
View the details of this partnering listing and connect directly with the teams behind promising technologies.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.